Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2023-12-13

Clinical Trial Update: Vonoprazan Study in Patients With Erosive Esophagitis to Evaluate Long-term Safety [Phase 4]

View source ↗

Summary

Phase 4 trial update evaluating long-term safety of vonoprazan in patients with erosive esophagitis; results posted.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Vonoprazan (vonoprazan)

Snippet

Sponsor: Takeda | Conditions: Erosive Esophagitis | Phase 4 | Status: COMPLETED | Results posted: 2023-12-13